Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. - Wikidata - awgldk - TriplyDB

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

http://www.wikidata.org/entity/Q34297783

about

Trash or Treasure: extracellular microRNAs and cell-to-cell communication Decoding the Secret of Cancer by Means of Extracellular Vesicles MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds Decoding the usefulness of non-coding RNAs as breast cancer markers Prognostic role of microRNA-203 in various carcinomas: evidence from a meta-analysis involving 13 studies Circulating microRNAs: potential biomarkers for common malignancies The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer miR-200-containing extracellular vesicles promote breast cancer cell metastasis.MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle Circulating tumor cells in breast cancer.An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells.Analysis of circulating tumor cells in breast cancer.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Prognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis.Plasma microRNA panel for minimally invasive detection of breast cancer Regulation of cancer metastasis by cell-free miRNAs.Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Circulating exosomal microRNAs as biomarkers of colon cancer.Special delivery: microRNA-200-containing extracellular vesicles provide metastatic message to distal tumor cells Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker MicroRNAs as potential biomarkers in cancer: opportunities and challenges Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis.MicroRNA-200 Family Profile: A Promising Ancillary Tool for Accurate Cancer Diagnosis Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.Development of a circulating miRNA assay to monitor tumor burden: From mouse to man microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.

P2860

Q21131238-2A96B719-C788-415D-B7B4-149CEB7E5109 Q26767179-500BC153-969B-43C9-B4DF-52EFDC322716 Q26775086-544809EA-7D64-45AA-A9DB-021C8A8A9BEF Q26778084-E9173A68-B697-424D-A4B6-107B13B59130 Q26782449-39D62169-560F-4A34-9E69-01D17F504FBD Q26782613-0E3B99F7-AA67-415D-91F0-F17AAA2DF9BE Q26786404-B5FD29F1-529A-4A91-A5E7-65208DCF69CA Q27013565-0A7C0864-5B34-48E1-963F-910C1AC8FE92 Q28069370-64D3F481-4C47-483B-A90A-7493B28EF7D5 Q28080063-E854236F-A586-4213-873D-C04698244F16 Q28081347-F3ACD8A2-4D83-4079-95CE-9EBA3BDCD79A Q28083742-34F61F3A-A9DF-4DF7-9DAC-EB178844A107 Q28291603-CAEF7EF4-A979-4147-AB5E-2CCECB6362FB Q30624403-7C74E09F-D9CE-4B05-83D5-0C4DD3F6F651 Q33585094-E9E3B7C5-B3A0-46AB-B9BD-2AAC9A477ED5 Q33599465-DB0DCC57-5499-4F90-9429-DC190B8702A8 Q33779244-24E7CA60-2477-4F28-A7AC-5CBF4B5B8662 Q33823829-5DBAFF0F-9C0B-4459-ABDA-8E8EA45A1AF0 Q33913895-22547241-6B97-4D26-94CA-9CD9DE30AAF6 Q34052685-2866368E-B101-4332-B2DB-6C94AB8CD990 Q34077349-FC280BF5-349E-47BB-B9E1-C04FA6BF9590 Q34150859-8B06889F-682A-42BA-9D53-28EF4CBC878B Q34156275-7A0FD55B-3312-4666-B39B-328C3534EEE9 Q34221705-5028E570-EA0F-4FE3-9842-EF87D1D3484A Q34488086-94F834F5-F7A4-44B3-9E4A-61136A062CC2 Q35032320-2B92B329-9235-465E-A660-FD11C36306C5 Q35034340-446C50C8-AB50-4B33-9A3D-3578A5D68A6A Q35106877-2C8C1D16-8B9D-4199-A9CC-9699F403252B Q35137273-1548D1BD-3083-446F-B1B4-E02AF47E842A Q35140085-24ED8F8C-CC20-43E9-B4A4-C123440ACBDF Q35145459-144D485C-1E66-4362-83D2-8F0C50BDFE32 Q35203556-F7663829-B3F6-42A9-B270-C97FE7F8CE4E Q35247522-40013785-C132-4F36-A730-BBED5E8BD281 Q35271157-C6B14338-FEBD-47EF-A1A0-EA49770581B6 Q35518887-E004D723-DBD8-4CC3-ABAB-43B6CD070E04 Q35675544-B1EB29B4-B89C-4829-863F-2C49382AB08D Q35855574-A61FEE49-2DFB-4A2D-BA9F-1C906DD70FC8 Q36356125-CB467D8E-B949-4983-AFC0-AD11295070FE Q36571424-66008223-C20A-4036-9088-D3E9CDB63F76 Q36647044-51B8AC16-CDDB-42C5-B919-84F3C7B5DCC0

P2860

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

http://www.wikidata.org/entity/Q34297783

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@ast

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@en

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@nl

type

label

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@ast

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@en

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@nl

prefLabel

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@ast

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@en

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@nl

P1433

Q34297783-85BC60B0-EED4-420F-8599-BA3C894B310B

P1476

Q34297783-25D572C2-BA56-481F-A8C0-3972755B6FB8

P2093

Q34297783-1BF32C0A-99EF-46DD-9887-DC26568C1A69

Q34297783-2D29C012-89A8-4644-A4C3-91D1BED794BD

Q34297783-4FBE3B6D-0AD7-4CB9-ACA7-3346E5F98F65

Q34297783-607E2926-5FC6-4D8F-9457-55C2C5539B95

Q34297783-9F7A4AD2-126A-4EB9-969A-21ABCCBBC5C8

Q34297783-A2861C32-3498-4CB0-B56D-83419E844ADC

Q34297783-B4CFB3CB-3C0E-4A89-9373-E3B082B81BA9

Q34297783-E5BE7FFA-8640-4C07-8216-8C0F0583C91F

Q34297783-F461C2EE-7F22-4308-8767-946D0E3D5EF2

Q34297783-FA98178B-EEBB-4B61-8007-065E62FA324B

P304

Q34297783-01B7BF98-DDF3-4F31-A1B5-FDA74CAD1361

P31

Q34297783-5A7E620E-A86E-48F7-9A4D-E58DB4A227DD

P356

Q34297783-2915A092-738F-4A05-A118-9E78499B5D6B

P407

Q34297783-2B30CB56-AB33-4CB9-8377-ED8F126F99CD

P433

Q34297783-2FE42F23-9FB5-4C3B-8645-6203C69AC92F

P478

Q34297783-639B25CA-D4D8-49E2-A00E-FAB6E23FB1DC

P50

Q34297783-1D11C94D-6A9C-472A-A8D2-4805F98AA775

Q34297783-1F02FFF6-B469-4179-9753-C83225E1E578

Q34297783-6868531A-28F6-487E-9813-F9138164F641

Q34297783-8AF88A30-52F3-4198-A008-77E23EAF453F

Q34297783-98B40CF9-8FF9-40C2-9C92-5FF19D2038CC

Q34297783-AAC84D7F-2ADA-49B8-895A-9554E43E5A38

Q34297783-ED0C30EB-607B-487E-9A1D-3172A2C8DB4D

P577

Q34297783-4C641989-B6A0-4DF4-9E0A-F10EC05BC57B

P5875

Q34297783-DC24842E-1CD9-45DF-9BB5-FCA5A32C69CE

P698

Q34297783-04C42647-4B34-47A9-8052-50BB10275E2A

P356

1078-0432.CCR-12-1407

P1433

Clinical Cancer Research

P1476

Circulating miRNAs as surrogat ...... s in metastatic breast cancer.

@en

P2093

Andrey Turchinovich

http://www.w3.org/2001/XMLSchema#string

Axel Benner

http://www.w3.org/2001/XMLSchema#string

Caroline Modugno

http://www.w3.org/2001/XMLSchema#string

Christof Sohn

http://www.w3.org/2001/XMLSchema#string

Dharanija Madhavan

http://www.w3.org/2001/XMLSchema#string

Jörg Heil

http://www.w3.org/2001/XMLSchema#string

Katarina Cuk

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Manuela Zucknick

http://www.w3.org/2001/XMLSchema#string

Markus Wallwiener

http://www.w3.org/2001/XMLSchema#string

P304

5972-5982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-12-1407

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Burwinkel

Andreas Schneeweiss

Sabine Riethdorf

Markus Wallwiener

Manuela Zucknick

P577

2012-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230804896

http://www.w3.org/2001/XMLSchema#string

P698

22952344

http://www.w3.org/2001/XMLSchema#string